Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 3/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919325 | 0.91 | MAPT (0.34) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919420 | 0.91 | MAPT (0.35) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919322 | 0.90 | L3MBTL1 (0.33) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919324 | 0.90 | MAPT (0.35) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919341 | 0.86 | MAPT (0.35) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL4083808 | 0.86 | MAPT (0.36) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919340 | 0.85 | TNKS (0.33) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL23919338 | 0.85 | TNKS (0.33) | MAPTL3MBTL1ATMALDH1A1HPGD | |
| SCHEMBL17036332 | 0.84 | ALOX5 (0.38) | MAPTPRKDC | |
| SCHEMBL12206486 | 0.84 | MAPT (0.35) | MAPTL3MBTL1ATMALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | MAPT 2477/4885L3MBTL1 2341/4885ATM 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.